458 related articles for article (PubMed ID: 7553864)
21. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
22. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR.
Zhang F; Kartner N; Lukacs GL
Nat Struct Biol; 1998 Mar; 5(3):180-3. PubMed ID: 9501909
[TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis problem probed by proteolysis.
Welsh MJ; Ostedgaard LS
Nat Struct Biol; 1998 Mar; 5(3):167-9. PubMed ID: 9501902
[No Abstract] [Full Text] [Related]
24. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
25. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
26. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.
Okiyoneda T; Harada K; Takeya M; Yamahira K; Wada I; Shuto T; Suico MA; Hashimoto Y; Kai H
Mol Biol Cell; 2004 Feb; 15(2):563-74. PubMed ID: 14595111
[TBL] [Abstract][Full Text] [Related]
27. Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae.
Kiser GL; Gentzsch M; Kloser AK; Balzi E; Wolf DH; Goffeau A; Riordan JR
Arch Biochem Biophys; 2001 Jun; 390(2):195-205. PubMed ID: 11396922
[TBL] [Abstract][Full Text] [Related]
28. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.
Rubenstein RC; Zeitlin PL
Am J Physiol Cell Physiol; 2000 Feb; 278(2):C259-67. PubMed ID: 10666020
[TBL] [Abstract][Full Text] [Related]
29. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
[TBL] [Abstract][Full Text] [Related]
30. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum.
Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD
Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343
[TBL] [Abstract][Full Text] [Related]
31. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
33. Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi.
Farinha CM; Matos P; Amaral MD
FEBS J; 2013 Sep; 280(18):4396-406. PubMed ID: 23773658
[TBL] [Abstract][Full Text] [Related]
34. The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator.
Chen EY; Clarke DM
BMC Biochem; 2002 Oct; 3():29. PubMed ID: 12361483
[TBL] [Abstract][Full Text] [Related]
35. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
Ma J; Lindquist S
Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
[TBL] [Abstract][Full Text] [Related]
36. In vitro reconstitution of CFTR biogenesis and degradation.
Oberdorf J; Skach WR
Methods Mol Med; 2002; 70():295-310. PubMed ID: 11917531
[No Abstract] [Full Text] [Related]
37. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
Gelman MS; Kopito RR
Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
[No Abstract] [Full Text] [Related]
38. A novel quality control compartment derived from the endoplasmic reticulum.
Kamhi-Nesher S; Shenkman M; Tolchinsky S; Fromm SV; Ehrlich R; Lederkremer GZ
Mol Biol Cell; 2001 Jun; 12(6):1711-23. PubMed ID: 11408579
[TBL] [Abstract][Full Text] [Related]
39. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
White AL; Guerra B; Wang J; Lanford RE
J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657
[TBL] [Abstract][Full Text] [Related]
40. Aggresomes: a cellular response to misfolded proteins.
Johnston JA; Ward CL; Kopito RR
J Cell Biol; 1998 Dec; 143(7):1883-98. PubMed ID: 9864362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
